Idéal Investisseur
Français English
CAC 40 : Market open
8 234,08 pts
+0.37%


Last updated : 10/06/2026 - 09h45

NANOBIOTIX news: financial news, earnings, stock moves and analysts

Live news related to NANOBIOTIX stock (FR0011341205): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.

The latest financial news on NANOBIOTIX mainly cover M&A activity, analyst notes et share price moves. The stock trades at €29,20 on Euronext Paris, up 1,39% at the last update. This page lists the articles published on NANOBIOTIX stock to track the share price, company announcements and any item likely to influence market perception.

Assurance vie
NANOBIOTIX
FR0011341205
Pharmaceuticals & Biotechnology / Biotechnology
29,20 € +1,39 %
High29,68 €
Low29,00 €
Last update : 10/06/2026 - 09:47:42 – Euronext Paris – 15 min delay.
Market open

Latest NANOBIOTIX stock news

The French biotech regains some color midday, after several sessions of decline. The stock is moving into positive territory in a Parisian market that…

The French biotech continues another session in the red as the Parisian market also declines. The movement is a continuation of a significant pullback…

The French biotech continues its decline in early afternoon, despite a boost from a leading analyst. The movement is part of a digestion phase that be…

Nanobiotix has strengthened its financial base by completing a capital increase of 86.1 million euros through pre-funded warrants, bringing its net ca…

The French biotech continues another session in the red while the Paris stock market trends upward. This movement occurs on the same day as the announ…

French biotech company Nanobiotix announced on Tuesday its inclusion in the Euronext Tech Leaders segment and the corresponding index, an initiative l…

The French biotech company experiences another challenging session at the start of the month. Its stock marks a significant decline while the Paris ma…

The French biotech regains its momentum in mid-session after several days of consolidation. The stock is rising while the broader Paris index is in th…

The French biotech continues its consolidation phase after an extraordinary stock market journey. The stock declines during the session while the Pari…

The French biotech company pauses in a declining Parisian market. The stock is experiencing a downturn after a tumultuous period marked by a global of…

Ad
Chaque matin
Les signaux techniques du marché,
avant l'ouverture.
CAC 40 · SBF 120 · Signaux · Analystes
🤖
Édition du jour — avant bourse
CAC 40
7 702
-0,87%
SBF 120
5 827
-0,87%
📈 Signaux haussiers
+5,2%
+1,8%
+0,9%
📉 Signaux baissiers
-14%
-5,7%
🔄 Avis analystes
▲ 35 €
▼ 80 €
Inscrivez-vous pour tout voir →
Avant 9h chaque matin
Données Euronext
Analyse automatique IA